Whalesbook
Billionaire investor Radhakishan Damani has increased his shareholding in niche chemical manufacturers Mangalam Organics and Bhagiradha Chemicals. This move targets the cyclical chemical sector, where both firms are undergoing significant capacity expansion. While the companies hold strong niche market positions, they face challenges including high debt levels and earnings volatility. Investors should track whether these expansion projects lead to improved profitability and how effectively the companies manage their balance sheets during the current industry downturn.
What Happened
Radhakishan Damani, the investor known for his long-term approach to business, has increased his shareholding in two specific companies in the chemical sector: Mangalam Organics and Bhagiradha Chemicals. His investment entities now hold a 2.2% stake in Mangalam Organics and a 3.3% stake in Bhagiradha Chemicals. Both companies operate in niche segments—Mangalam in pine chemistry and Bhagiradha in agrochemicals—that are essential to broader global supply chains but are currently facing the pressures of a cyclical downturn.
The Strategy Behind the Bets
These investments appear to focus on companies undergoing significant capital spending. Both Mangalam Organics and Bhagiradha Chemicals have invested heavily in expanding their manufacturing capacity, despite the current sluggish demand in their respective sectors. For investors, this pattern often suggests a bet on a future cyclical recovery. If the demand for their products rebounds as these new facilities come online, the companies could see improved efficiency and profitability. However, this strategy carries the risk of higher debt and financial pressure until the expansion projects begin to generate sufficient returns.
Mangalam Organics: Debt and Capacity
Mangalam Organics is a notable player in the pine chemistry space and produces camphor, terpene derivatives, and synthetic resins. Its products are vital for industries like rubber and adhesives. The company has expanded its manufacturing capabilities, which led to a rise in total borrowings from Rs 20 crore to Rs 359 crore. This rapid buildup of debt has naturally put pressure on the company's free cash flow. While the company has seen annual sales growth of roughly 13% over the last five years, its profits have been volatile, moving from a profit of Rs 85 crore in FY21 to a loss of Rs 27 crore in FY23. The key for investors here is to see if the new capacity can improve operational performance and help the company manage its debt load.
Bhagiradha Chemicals: The Agrochemical Play
Bhagiradha Chemicals manufactures active ingredients for agrochemicals, with a strong export footprint in markets such as the USA, Brazil, and Australia. Similar to Mangalam, the company has ramped up its fixed assets, growing from Rs 245 crore to Rs 581 crore through a new plant installation. This capital spending has temporarily depressed return ratios, with the return on capital employed currently around 5%. The stock is trading at a high price-to-earnings ratio of 185x, which reflects the sharp decline in recent earnings rather than an expensive valuation of future growth. As the company works through the current global destocking cycle, the focus for shareholders remains on whether these new assets can drive revenue growth once the agricultural cycle turns positive.
What Could Go Wrong
The primary risk for both companies is the nature of their cyclical business. When the industry faces a downturn, demand for commodities like camphor or specific agrochemical ingredients can drop, squeezing profit margins. Additionally, the significant debt taken on for expansion creates a financial burden. If the expected demand recovery is delayed, or if the new capacity is not utilized efficiently, these companies may struggle to service their debt or maintain consistent profitability. Investors should also note that promoter holdings and corporate governance are critical points to monitor in firms undergoing aggressive expansion.
What Investors Should Track
Going forward, the most important factor is the utilization of the new capacity. Investors may track quarterly results to see if margins are expanding or if the debt burden is stabilizing. For Mangalam Organics, monitoring the reduction in debt and the success of its consumer brand, CamPure, will be useful. For Bhagiradha Chemicals, tracking global export demand for its agrochemical ingredients and any signs of improvement in the industry's pricing cycle will be key to understanding the potential for a rebound.
